Navigation Links
'Fat, Fate and Disease'
Date:1/17/2012

Is exercise and health eating enough?

Can a one-size-fits all approach really work?

The world is encountering an epidemic of obesity, heart disease and diabetes. In the west it is already widespread and it is now exploding in the developing world with the rapid change in the lifestyles of recent generations.

"Fat, Fate and Diseases" explores the dominant myth that this epidemic can be tackled by focusing solely on adult lifestyles and asks the simple question: 'why are we losing the war against obesity and chronic diseases?'

World experts Sir Peter Gluckman and Professor Mark Hanson argue that the only public health strategy currently on offer diet and exercise has no chance of succeeding. The latest scientific evidence shows that much of the problem emerges in early life and even before birth. Social, cultural and biological factors are hugely important and there can be no 'one-size-fits all' solution, as different populations and people respond differently to living in the modern nutritionally rich world. Currently, these issues are being ignored in the fight against lifestyle diseases.

This fascinating book identifies the need to address these issues in two dimensions a life course approach and consideration of the developmental challenges of countries emerging from socioeconomic transition. The authors discuss the complex interactions between health care and the food industry, suggesting that the food industry must be co-opted as an ally in this battle.

"Fat, Fate and Diseases" suggests new pathways forward in the battle against obesity and other lifestyle diseases.

  • Discusses the flawed approach to the weight-loss industry
  • Shows how scientific enterprise ignores the reality of the social, cultural and biological determinants
  • Reviews the scientific evidence that much of the problem emerges in early life and even before birth
  • It asks why the major global bodies fail to consi
    '/>"/>

Contact: Gabby Fletcher
gabby.fletcher@oup.com
01-865-353-969
Oxford University Press
Source:Eurekalert

Page: 1 2

Related biology news :

1. More fiber, but not necessarily less fat, good for teen diets
2. Moms who eat high-fat diet before, during pregnancy program babies to be fat, at risk
3. Exercise boosts health by influencing stem cells to become bone, not fat, McMaster researchers find
4. Eating low-fat, thanks to lupin proteins
5. Flavonoids in orange juice suppress oxidative stress from high-fat, high-carb meal
6. Low levels of vitamin D linked to muscle fat, decreased strength in young people
7. Canadian-led research team develop new model to anticipate disease outbreaks at 2012 Olympics
8. The microbiome and disease: Gut bacteria influence the severity of heart attacks in rats
9. Research team discovers genes and disease mechanisms behind a common form of muscular dystrophy
10. Discovery could help stem smoking-related diseases
11. Study establishes importance of tracking diseases associated with illegal wildlife trade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
(Date:3/11/2015)...   The Sync Project™ today announced ... and harness music to improve health. The platform ... measurements of physiology, enabling the study of the ... populations. It is designed for medical and health ... studies and accelerate the discovery of the clinical ...
(Date:3/10/2015)... March 10, 2015 Transforming How ... "Personalized Medicine in Human Space Flight" by ... J. Goodwin , Ph.D. was recently featured by Springer ... two years. Specifically, "Personalized Medicine in Human ... papers published in 2013 and 2014 from Springer in ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... Treatment with the oral antiviral Tamiflu (oseltamivir) and ... be one of the most cost-effective strategies for ... According to modelling research presented by Beate Sander, ... sufficient to cover 65% of a country’s population ...
... serve as biofactories for the production of various beneficial ... new genes into mushrooms. , "There has always been ... choice platform for the mass production of commercially valuable ... B. Swayne Chair in spawn science and professor of ...
... causes disease have come to a simple conclusion -- ... might help them find a new treatment for what can ... genes responsible for toxin production only seem to be expressed ... with the view that most disease-causing bacteria express their pathogenicity ...
Cached Biology News:Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention 2Modified mushrooms may yield human drugs 2Understanding why C. difficile causes disease -- it's hungry 2
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) fertilizers ... high prices in 2008. However, the situation has stabilised ... gaining momentum now. , To date, the world annual ... thousand tonnes. No considerable growth was registered in the ... during 2012-2013, registering 11% growth as against the period ...
(Date:3/27/2015)... Mich. , March 27, 2015  Neogen Corporation ... LLC, has adopted a prearranged trading plan in accordance ... Herbert , Chairman and CEO of Neogen Corporation, is ... of Neogen Corporation common stock. Herbert does ... disclosure was appropriate. The filing is only for a ...
(Date:3/27/2015)... March 27, 2015  Peter Walter was chosen as ... his pioneering work on how proteins are transported between ... regulatory mechanism that cells use to handle stress tied ... a professor of biochemistry at the University of California, ... a range of human diseases related to defective protein ...
(Date:3/27/2015)... , March 27, 2015 WuXi ... leading open-access R&D capability and technology platform company ... industries, announced today that an Investigational New Drug ... antibody for rheumatoid arthritis has been accepted for ... (CFDA).  In September 2012, MedImmune, ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3
... the Phase III Clinical Development and ... of THR-100 in Developing Countries, LEUVEN, Belgium, ... biotechnology company focused on vascular disease, today,announced the ... International Limited (Hyderabad, India) for the manufacture of,THR-100, ...
... Collaboration With CDC to Ensure US,s Preparedness ... Public Health Emergency, CAMBRIDGE, England and CAMBRIDGE, ... a leading,vaccine company, announced today that the US ... (Smallpox (Vaccinia) Vaccine, Live) vaccine,for protection against smallpox. ...
... Sept. 3 Leading neurosurgical device,developer Elekta ... and treatment devices, along with clinical workflow ... at the European,Association of Neurosurgical Societies (EANS) ... neurosurgeons and related medical professionals,will gather at ...
Cached Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 2FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 3FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 5Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 2Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 3Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 4
96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
...
Immulon 1 B 1x12 Strip, flat bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
Biology Products: